Insulet (PODD) Depreciation & Amortization (CF) (2010 - 2026)
Insulet (PODD) reported Depreciation & Amortization (CF) of $26.2 million for Q1 2026, up 20.74% on a YoY basis from $21.7 million in Q1 2025, and up 7.38% quarter-over-quarter from $24.4 million in Q4 2025.
Insulet (PODD) Depreciation & Amortization (CF) (2010 - 2026) Analysis & Trends
Insulet has reported Depreciation & Amortization (CF) for 17 years, with the latest figure at $26.2 million in Q1 2026.
- For the quarter ending Q1 2026, Depreciation & Amortization (CF) rose 20.74% year-over-year to $26.2 million; the trailing twelve-month figure through Mar 2026 stood at $94.9 million (up 13.38% YoY), and the FY2025 full-year result was $90.4 million, up 11.88% from the prior year.
- Depreciation & Amortization (CF) for Q1 2026 stood at $26.2 million, up from $24.4 million in the prior quarter.
- The five-year high for Depreciation & Amortization (CF) was $26.2 million in Q1 2026, with the low at $15.3 million in Q1 2022.
- Historically, Depreciation & Amortization (CF) has averaged $19.6 million across 5 years, with a median of $18.8 million in 2023.
- Annual changes were most pronounced in 2025 — Depreciation & Amortization (CF) climbed 3.29% — and 2026, when it increased 20.74%.
- Insulet's Depreciation & Amortization (CF) stood at $16.2 million in 2022, then increased by 16.05% to $18.8 million in 2023, then increased by 14.36% to $21.5 million in 2024, then gained by 13.49% to $24.4 million in 2025, then increased by 7.38% to $26.2 million in 2026.
- The last three Depreciation & Amortization (CF) figures came in at $26.2 million (Q1 2026), $24.4 million (Q4 2025), and $22.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 381.00 Mn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 120.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 749.00 Mn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 351.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 40.90 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 67.10 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 78.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 123.40 Mn |
| 10 | Insulet | 10.20 Bn | 9.72 Bn | 529.10 Mn | 26.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 26.20 Mn |
| Mar 31, 2026 | 26.20 Mn |
| Dec 31, 2025 | 24.40 Mn |
| Dec 31, 2025 | 24.40 Mn |
| Sep 30, 2025 | 22.00 Mn |
| Sep 30, 2025 | 22.00 Mn |
| Jun 30, 2025 | 22.30 Mn |
| Jun 30, 2025 | 22.30 Mn |
| Mar 31, 2025 | 21.70 Mn |
| Mar 31, 2025 | 21.70 Mn |
| Dec 31, 2024 | 21.50 Mn |
| Dec 31, 2024 | 21.50 Mn |
| Sep 30, 2024 | 21.30 Mn |
| Sep 30, 2024 | 21.30 Mn |
| Jun 30, 2024 | 19.20 Mn |
| Jun 30, 2024 | 19.20 Mn |
| Mar 31, 2024 | 18.80 Mn |
| Mar 31, 2024 | 18.80 Mn |
| Dec 31, 2023 | 18.80 Mn |
| Dec 31, 2023 | 18.80 Mn |